Navigation Links
Interleukin Genetics Reports Fourth Quarter and Year End 2010 Financial Results
Date:3/21/2011

cit$
(6,658,096)$
(5,764,628)Total liabilities and shareholders' deficit$
5,975,000$
3,069,463Statement of Operations Data :Three Months Ended December 31, Twelve Months Ended December 31, 2010200920102009Revenue:Genetic testing service revenue$
479,589$
53,784$  1,940,190$
505,914Contract research revenue-24,912-545,847Other31,1786,39556,98326,669Total revenue510,767185,0911,997,1731,078,430Cost of Revenue364,808291,4971,618,8411,203,647Gross profit (loss)145,959(106,406)378,332(125,217)Operating costs and expenses:Research and development497,452584,1721,925,9753,213,115Research and development reimbursement grant(473,394)-(473,394)-Selling, general and administrative1,173,0971,102,0515,013,9035,575,911Amortization of intangibles28,86328,863115,453115,453Total operating expenses1,226,0181,715,0866,581,9378,904,479Loss from operations(1,080,059)(1,821,492)(6,203,605)(9,029,696)Total other income and (expense), net(87,844)(50,119)(265,215)(148,577)Loss from continuing operationsbefore provision for income taxes(1,167,903)(1,871,611)(6,468,820)(9,178,273)Provision for income taxes----Loss from continuing operations(1,167,903)(1,871,611)(6,468,820)(9,178,273)Income (loss) from discontinued Operations,net of  tax-31,084482,530(1,374,130)Net loss$
(1,167,903)$
(1,840,527)$ (5,986,290)$ (10,552,403)Basic and diluted net income (loss) per common share from:Continuing operations$
(0.03)$
(0.06)($0.18)($0.29)Discontinued operations0.000.000.01(0.04)Net loss$
(0.03)$
(0.06)($0.17)($0.33)Weighted average common shares outstanding,basic and diluted36,583,33032,102,40735,706,27132,007,826
'/>"/>
SOURCE Interleukin Genetics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Interleukin Genetics, Inc. to Present at Biotech Showcase 2011
2. Interleukin Genetics, Inc. Receives Delisting Notification from NYSE Amex
3. Interleukin Genetics to Present at Upcoming Biotech Industry Meetings
4. Interleukin Genetics to Present at the 12th Annual BIO CEO Conference
5. Continued Uptake of TNF-Alpha Inhibitors and Interleukin Inhibitors Will Drive $2.2 Billion Growth in the Psoriasis Drug Market
6. Interleukin Genetics Reports Second Quarter 2009 Financial Results
7. Interleukin Genetics Announces Conference Call To Discuss Second Quarter 2009 Results
8. Interleukin Genetics to Present at the 2009 BIO Business Forum
9. Interleukin Genetics Reports Fourth Quarter and Year End 2008 Financial Results
10. Interleukin Genetics Receives Notification of Failure to Meet Continued Listing Standard Section 1003(a)(iii)
11. Interleukin Genetics Appoints Todd Anthony Walker as Vice President, Marketing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the Company") today announced results ... 2015 first quarter financial statements and MD&A have been filed on ... March 31,(in CDN$,000 except per share data) , 2015 ... Gross profit , 1,531 , 329 Ebitda* , ... 528 , (531) Basic earnings (loss) per share ...
(Date:6/1/2015)... 01, 2015 Regis Technologies, Inc. ... of chiral stationary phases (CSPs) for analytical and ... current and presenting solutions for new clients, Regis ... This valuable addition to its core expertise in ... that can tackle projects for the scale clients ...
(Date:6/1/2015)... -- Neogen Corporation (NASDAQ: NEOG ) announced today that it ... commercial food testing laboratory based in southwest India ... a base for the company,s new operations in ... was incorporated in 1990, and its business has grown ... quality testing for major hotels and restaurants in its home ...
(Date:6/1/2015)... 2015 Esperance Pharmaceuticals Inc. today reported positive ... EP-100 in ovarian cancer patients resistant to paclitaxel. EP-100 ... destroy cancer cells that overexpress luteinizing hormone-releasing hormone (LHRH) ... a wide range of cancers. Results ... EP-100 were presented at the 2015 ASCO Annual ...
Breaking Biology Technology:Biorem Reports Increased Revenues and Earnings for First Quarter 2Biorem Reports Increased Revenues and Earnings for First Quarter 3Regis Technologies Offers Chiral Chromatography Service 2Regis Technologies Offers Chiral Chromatography Service 3Neogen acquires India food safety company 2Esperance Reports Positive EP-100 Phase ll Results in Ovarian Cancer at 2015 ASCO Annual Meeting 2Esperance Reports Positive EP-100 Phase ll Results in Ovarian Cancer at 2015 ASCO Annual Meeting 3
... Inc., a privately held,biopharmaceutical company focused on ... today announced a company,restructuring that includes the ... significant reduction in work force, primarily in ... company,s burn rate and refocuses,Sangart,s business units ...
... 7 GlaxoSmithKline plc (LSE/NYSE: GSK ) ... by its wholly-owned subsidiary Gemstone Acquisition Corporation for shares ... GNLB ). The tender offer expired at 12:00 ... 2009.The depositary for the tender offer has advised GSK ...
... REDWOOD CITY, Calif., Jan. 7 Codexis, Inc. today ... produce an,important publicly-undisclosed generic product, using a proprietary Codexis,biocatalyst. ... world, is a,leading producer of this generic product. ... drugs in the United States. , ...
Cached Biology Technology:Sangart, Inc. Announces Key Executive Appointments and Company Restructuring 2Sangart, Inc. Announces Key Executive Appointments and Company Restructuring 3GlaxoSmithKline Successfully Completes Tender Offer for Shares of Genelabs Technologies, Inc. 2Codexis, Teva in Licensing Agreement Final 2
(Date:5/19/2015)... May 19, 2015 ... the addition of the  "Genetic Testing Market ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,A recent report, Genetic ... analysis of the current and future genetic ... tests, their working principles and types are ...
(Date:5/14/2015)... 14, 2015 Research and Markets ( ... "Fingerprint Sensors Market in Smart Mobile Devices " ... that 2014 was a watershed year for fingerprint sensors ... ,Apple Pay,. Apple gave fingerprint sensors a raison d,etre ... Fingerprint sensors are a must-have feature in flagship smartphones. ...
(Date:5/11/2015)... Calif. , May 11, 2015  Synaptics ... of human interface solutions, today announced the appointment ... President and Chief Financial Officer, reporting to ... replaces Synaptics, current Chief Financial Officer, Kathleen ... 2014. Mr. Ali brings extensive ...
Breaking Biology News(10 mins):Global Genetic Testing Market Outlook 2018 2Global Smart Mobile Devices Fingerprint Sensors Market 2015-2019: Key Vendors are Authentec, Validity Sensors, Fingerprint Cards, Next Biometrics Group. IDEX, and Qualcomm 2Synaptics Appoints Wajid Ali as Senior Vice President and Chief Financial Officer 2
... vaccine that enlists help from the immune system to keep ... to help smokers quit and to limit the urge to ... being developed by Nabi Biopharmaceuticals to prevent and treat nicotine ... smoker inhales, nicotine is carried by the bloodstream to the ...
... Scientists at the Albert Einstein College of Medicine of ... gene expression can occur in the form of discrete ... techniques, developed by Dr. Robert Singer and colleagues at ... directly watch the behavior of a single gene in ...
... subpopulation of helper T-cells provides immunity and promotes survival ... means of predicting an AIDS vaccine's effectiveness, a discovery ... in clinical trials. , Led by researchers at Beth ... Center (VRC) at the National Institute of Allergy and ...
Cached Biology News:Einstein researchers take the pulse of a gene in living cells 2AIDS vaccine research offers new insights on survival 2AIDS vaccine research offers new insights on survival 3
X-gal,1g...
Standard 2" or 3" Plastic can be ordered with 81 or 100 cell dividers. Mini 2" Plastics Boxes come standard with 25 cell dividers. Plastic boxes can also be ordered with corresponding freezer racks...
... Conjugation, Quantities to Kilograms, ... Special amino acids and their ... labeling AMC, aldehyde, CMK, Purity ... Chromogenic/Flurogenic Substrates, Solid Phase/Solution/Segment ...
... The Gla-type Osteocalcin EIA Kit is ... kit for quantitative determination of human ... cell culture supernatants, and other biological ... research use only. It is not ...
Biology Products: